Cargando…

Impact of Postmastectomy Radiotherapy on Locoregional Control and Disease-Free Survival in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy

BACKGROUND: The impact of postmastectomy radiotherapy (PMRT) in patients receiving neoadjuvant chemotherapy (NAC) is unclear. The purpose of this study is to identify the patients who may benefit from PMRT. METHODS: We retrospectively analysed patients with clinical stage II-III breast cancer who un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanyu, Zhang, Yaotian, Liu, Zhuang, Qin, Zilan, Li, Yubing, Zhao, Jiaming, Ma, Xinchi, Yang, Qiankun, Han, Ning, Zeng, Xue, Guo, Hong, Zhang, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850833/ https://www.ncbi.nlm.nih.gov/pubmed/33564308 http://dx.doi.org/10.1155/2021/6632635

Ejemplares similares

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma
por: Zhang, Yaotian, et al.
Publicado: (2022)

Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen
por: Wang, Hongyue, et al.
Publicado: (2021)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
por: Kheradmand, Ali Arab, et al.
Publicado: (2010)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
por: Wang, Xin, et al.
Publicado: (2018)

A New Model for Predicting Nonsentinel Lymph Node Metastasis in Early-Stage Breast Cancer Using MMP15
por: Zeng, Xue, et al.
Publicado: (2022)

Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020)

Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy
por: Wen, Ge, et al.
Publicado: (2016)

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Correction: Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
por: Zhang, Chi, et al.
Publicado: (2015)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
por: Van der Vorst, Aline, et al.
Publicado: (2022)

Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in cT(1-2)N(+) Breast Cancer Patients: A Single Center Experience and Review of Current Literature
por: Luo, Meng, et al.
Publicado: (2022)

Automated treatment planning of postmastectomy radiotherapy
por: Kisling, Kelly, et al.
Publicado: (2019)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
por: Herrero-Vicent, C, et al.
Publicado: (2016)

Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
por: Huang, Liang, et al.
Publicado: (2016)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
por: Wee, Chan Woo, et al.
Publicado: (2015)

LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression
por: Zhang, Na, et al.
Publicado: (2019)

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015)

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2020)

Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk Analysis
por: Zhang, Jian, et al.
Publicado: (2017)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis
por: Zhang, Jiaqiang, et al.
Publicado: (2020)

Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
por: Gong, Pan, et al.
Publicado: (2022)

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
por: Liu, Jieqiong, et al.
Publicado: (2015)

MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8
por: Zeng, Xue, et al.
Publicado: (2021)

The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2021)

Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
por: Kim, Dowook, et al.
Publicado: (2023)

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
por: Qiu, Wen-Ze, et al.
Publicado: (2016)

Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis
por: Wang, Xiaojuan, et al.
Publicado: (2022)

Flattening Filter-Free Volumetric-Modulated Arc Radiotherapy for Left-Sided Whole-Breast, Partial-Breast, and Postmastectomy Irradiations
por: Zhang, Rui, et al.
Publicado: (2022)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Li, Ying, et al.
Publicado: (2023)

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2017)

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels
por: Takahashi, Jun, et al.
Publicado: (2018)

Dosimetric assessment of brass mesh bolus for postmastectomy photon radiotherapy
por: Manger, Ryan, et al.
Publicado: (2016)

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis
por: Fangzheng, Wang, et al.
Publicado: (2017)

Adjuvant postmastectomy radiotherapy might be associated with better survival in women with heart failure receiving total mastectomy
por: Zhang, Jiaqiang, et al.
Publicado: (2022)

Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
por: Chen, Yu-Pei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7ft21htk9a7hg1ehnt97peatm0